Showing results (31-40 of 4,034) with videos related to

Sort By:
Pageof 404
Pharmacoepidemiology and Drug Safety|November 16, 2018
Use of tumor necrosis factor-alpha inhibitors during pregnancy among women who delivered live born infantsEfe Eworuke, Genna Panucci, Margie Goulding, et al.
Pharmacoepidemiology and Drug Safety|April 5, 2019
The utilization and challenges of Japan's MID-NET® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studiesKaori Yamada, Maori Itoh, Yoshiaki Fujimura, et al.
Pharmacoepidemiology and Drug Safety|February 22, 2019
Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debateDanni Zheng, Sujita W Narayan, Helga Zoega, et al.
Pharmacoepidemiology and Drug Safety|January 22, 2021
Bottleneck analysis: Simple prediction of the precision of a planned case-control or cohort study based on healthcare registersJesper Hallas, Morten Rix Hansen, Anton Pottegård, et al.
Pharmacoepidemiology and Drug Safety|August 27, 2020
Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilanceEng Hooi Tan, Zheng Jye Ling, Pei San Ang, et al.
Pharmacoepidemiology and Drug Safety|August 27, 2020
Real-world effectiveness of pembrolizumab in previously treated non-small cell lung cancer: A population-based cohort studyRodrigo Murteira, Fábio Cardoso Borges, Gonçalo Pinto Mendes, et al.
Pharmacoepidemiology and Drug Safety|August 27, 2020
Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapySara E Hallvik, Kirbee Johnston, Jonah Geddes, et al.
Pharmacoepidemiology and Drug Safety|December 11, 2021
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapiesSara N Levintow, Kate K Orroth, Alexander Breskin, et al.
Pharmacoepidemiology and Drug Safety|December 13, 2021
Initiation of quarterly palmitate paliperidone in French clinical practice: Results from the observational, cross-sectional OPTIMUS studyCharlotte Gary, Cécile Déal, Jennifer Boursicot-Beuzelin, et al.
Pharmacoepidemiology and Drug Safety|January 20, 2022
The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysisTurki A Althunian, Maha I Alomran, Ghada M Alsagri, et al.
Pageof 404